| 1 |
34189121 | Simulating ATO Mechanism and EGFR Signaling with Fuzzy Logic and Petri Net. | 2021 Jun |
6 |
| 2 |
29274334 | Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform. | 2018 Feb 5 |
3 |
| 3 |
30237564 | Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer. | 2018 Sep 20 |
10 |
| 4 |
25791921 | TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis. | 2015 May 15 |
1 |
| 5 |
24927258 | Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade. | 2014 |
1 |
| 6 |
23178716 | SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells. | 2013 Jan 4 |
4 |
| 7 |
23548265 | Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair. | 2013 Jun |
7 |
| 8 |
22532027 | NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes. | 2012 Jun |
4 |
| 9 |
21649584 | Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. | 2011 Sep 1 |
1 |
| 10 |
20435036 | Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. | 2010 Aug 1 |
1 |
| 11 |
15961274 | As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells. | 2006 Feb |
3 |